Skip to main content
SpringerLink
Log in

Ebrotidine

A Viewpoint by Stanislaw J. Konturek

  • New Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Konturek SJ, Kwiecien N, Sito E, et al. Effects of ebrotidine on aspirin-induced gastric mucosal damage and blood flow in humans. Scand J Gastroenterol 1993 Dec; 28: 1047–50

    Article  PubMed  CAS  Google Scholar 

  2. Konturek SJ, Maczka J, Kaminski K, et al. Gastroprotective and antisecretory effects of ebrotidine. Scand J Gastroenterol 1992 Jun; 27 (6): 438–32

    Article  PubMed  CAS  Google Scholar 

  3. Konturek SJ, Kwiecien N, Obtulowicz W, et al. Comparison of gastroprotective and inhibitory activities of ebrotidine and ranitidine in humans [abstract]. Gastroenterology 1994 Apr; 106 Suppl.: A111

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Physiology, Jagiellonian University School of Medicine, Krakow, Poland

    Stanislaw J. Konturek

Authors
  1. Stanislaw J. Konturek
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Konturek, S.J. Ebrotidine. Drugs 51, 981 (1996). https://doi.org/10.2165/00003495-199651060-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199651060-00007

Keywords

Search

Navigation